Table 5 Medication usage for gastrointestinal conditions after surgery among participants
From: Long-term outcomes of colectomy surgery among patients with ulcerative colitis
Medication usage reported among LOCUS Participants (N = 160) | % |
|---|---|
Medications to regulate bowel movements (loperamide, codeine) | 99/160 (61 %) |
Antibiotics (ciprofloxacin, metronidazole) | 23/160 (14 %) |
Immune-modulating agents (thiopurines, anti-TNF monoclonal antibodies, methotrexate) | 9/160 (6 %) |
Aminosalicylates | 7/160 (4 %) |
Proton pump inhibitors | 5/160 (3 %) |
Analgesics (fentanyl, acetaminophen, gabapentin) | 5/160 (3 %) |
Supplements (iron, B12, probiotics) | 4/160 (3 %) |
Antispasmodics (anti-cholinergics) | 4/160 (2 %) |
Steroids (rectal steroids, prednisone) | 3/160 (2 %) |
Other medications for heartburn or nausea | 1/160 (2 %) |